Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 9Active not recruiting 8Recruiting 4Terminated 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Burkitt Lymphoma 1

Interventions

pembrolizumab 31Carboplatin 18Cisplatin 15Nivolumab 14Pemetrexed 12Paclitaxel 12Ipilimumab 11atezolizumab 10Gemcitabine 10Radiotherapy 9Docetaxel 9venetoclax 8durvalumab 8Cyclophosphamide 8fludarabine 7Biopsy 7tislelizumab 6enzalutamide 6Trastuzumab 6Specimen Handling 6Bevacizumab 6tazemetostat 5fludarabine phosphate 5Surveys and Questionnaires 5Radiosurgery 5Practice Guidelines as Topic 5Magnetic Resonance Spectroscopy 5Injections 5Dexamethasone 5Cetuximab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Peripheral Blood Stem Cell Transplantation × 90 days × Clear all
NCT03856216 2026-04-15

Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation

M.D. Anderson Cancer Center

Phase 2 Terminated
15 enrolled 11 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡